Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 50 of 465

1.

Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.

Palmer ND, Langefeld CD, Ziegler JT, Hsu F, Haffner SM, Fingerlin T, Norris JM, Chen YI, Rich SS, Haritunians T, Taylor KD, Bergman RN, Rotter JI, Bowden DW.

Diabetologia. 2009 Nov 10. [Epub ahead of print]PMID: 19902172 [PubMed - as supplied by publisher]Related articles

2.

Performance Characteristics of the New Definition of Diabetes: The Insulin Resistance Atherosclerosis Study (IRAS).

Lorenzo C, Haffner SM.

Diabetes Care. 2009 Oct 30. [Epub ahead of print]PMID: 19880585 [PubMed - as supplied by publisher]Related articles

3.

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.

Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; the A Diabetes Outcome Progression Trial Study Group.

J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19875477 [PubMed - as supplied by publisher]Related articles

4.

Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study.

Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM; for the Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation and Thrombosis Research Group.

Diabetes Care. 2009 Oct 19. [Epub ahead of print]PMID: 19841042 [PubMed - as supplied by publisher]Related articles

5.

Insulin Resistance, {beta}-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study (IRAS).

Lorenzo C, Wagenknecht LE, D'Agostino RB Jr, Rewers MJ, Karter AJ, Haffner SM.

Diabetes Care. 2009 Oct 6. [Epub ahead of print]PMID: 19808919 [PubMed - as supplied by publisher]Related articles

6.

Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial).

Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; for the ADOPT Study Group.

Diabetes Care. 2009 Oct 16. [Epub ahead of print]PMID: 19808911 [PubMed - as supplied by publisher]Related articles

7.

Variant in the 3' Region of the IkappaBalpha Gene Associated With Insulin Resistance in Hispanic Americans: The IRAS Family Study.

Miller MR, Zhang W, Sibbel SP, Langefeld CD, Bowden DW, Haffner SM, Bergman RN, Norris JM, Fingerlin TE.

Obesity (Silver Spring). 2009 Oct 1. [Epub ahead of print]PMID: 19798070 [PubMed - as supplied by publisher]Related articles

8.

Pulse pressure, prehypertension, and mortality: the San Antonio heart study.

Lorenzo C, Aung K, Stern MP, Haffner SM.

Am J Hypertens. 2009 Nov;22(11):1219-26. Epub 2009 Aug 20.PMID: 19696747 [PubMed - indexed for MEDLINE]Related articles

9.

Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.

Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM, Bergman R, Haffner SM.

Diabetologia. 2009 Oct;52(10):2079-86. Epub 2009 Jul 31.PMID: 19641896 [PubMed - in process]Related articles

10.

Is prehypertension a risk factor for the development of type 2 diabetes?

Mullican DR, Lorenzo C, Haffner SM.

Diabetes Care. 2009 Oct;32(10):1870-2. Epub 2009 Jul 23.PMID: 19628813 [PubMed - in process]Related articles

11.

Dual renin-angiotensin system blockade and kidney disease.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.

J Am Coll Cardiol. 2009 Jul 14;54(3):278-9; author reply 279-80. No abstract available. PMID: 19589445 [PubMed - indexed for MEDLINE]Related articles

12.

Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.

Lorenzo C, Williams K, Stern MP, Haffner SM.

Metabolism. 2009 Nov;58(11):1530-5. Epub 2009 Jul 7.PMID: 19586642 [PubMed - indexed for MEDLINE]Related articles

13.

Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.

Wagenknecht LE, Scherzinger AL, Stamm ER, Hanley AJ, Norris JM, Chen YD, Bryer-Ash M, Haffner SM, Rotter JI.

Obesity (Silver Spring). 2009 Jun;17(6):1240-6. Epub 2009 Feb 19.PMID: 19584882 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.

Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, Norris JM.

J Clin Endocrinol Metab. 2009 Sep;94(9):3306-13. Epub 2009 Jun 23.PMID: 19549738 [PubMed - indexed for MEDLINE]Related articles

15.

Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study.

Liese AD, Nichols M, Sun X, D'Agostino RB Jr, Haffner SM.

Diabetes Care. 2009 Aug;32(8):1434-6. Epub 2009 Jun 1.PMID: 19487638 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study.

Norris JM, Langefeld CD, Talbert ME, Wing MR, Haritunians T, Fingerlin TE, Hanley AJ, Ziegler JT, Taylor KD, Haffner SM, Chen YD, Bowden DW, Wagenknecht LE.

Obesity (Silver Spring). 2009 Oct;17(10):1932-41. Epub 2009 May 21.PMID: 19461586 [PubMed - in process]Related articles

17.

Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.

Schmitz KJ, Skinner HG, Bautista LE, Fingerlin TE, Langefeld CD, Hicks PJ, Haffner SM, Bryer-Ash M, Wagenknecht LE, Bowden DW, Norris JM, Engelman CD.

Am J Hypertens. 2009 Aug;22(8):867-70. Epub 2009 May 14.PMID: 19444222 [PubMed - indexed for MEDLINE]Related articles

18.

A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).

Rich SS, Goodarzi MO, Palmer ND, Langefeld CD, Ziegler J, Haffner SM, Bryer-Ash M, Norris JM, Taylor KD, Haritunians T, Rotter JI, Chen YD, Wagenknecht LE, Bowden DW, Bergman RN.

Diabetologia. 2009 Jul;52(7):1326-33. Epub 2009 May 9.PMID: 19430760 [PubMed - indexed for MEDLINE]Related articles

19.

Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).

Dasgupta A, Steinhubl SR, Bhatt DL, Berger PB, Shao M, Mak KH, Fox KA, Montalescot G, Weber MA, Haffner SM, Dimas AP, Steg PG, Topol EJ; CHARISMA Investigators.

Am J Cardiol. 2009 May 15;103(10):1359-63. Epub 2009 Apr 1.PMID: 19427428 [PubMed - indexed for MEDLINE]Related articles

20.

Risk of type 2 diabetes among individuals with high and low glomerular filtration rates.

Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Gelfond JA, Haffner SM.

Diabetologia. 2009 Jul;52(7):1290-7. Epub 2009 Apr 15.PMID: 19367385 [PubMed - indexed for MEDLINE]Related articles

21.

Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort.

Beihl DA, Liese AD, Haffner SM.

Ann Epidemiol. 2009 May;19(5):351-7.PMID: 19362278 [PubMed - indexed for MEDLINE]Related articles

22.

INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.

Talbert ME, Langefeld CD, Ziegler JT, Haffner SM, Norris JM, Bowden DW.

Obesity (Silver Spring). 2009 Aug;17(8):1554-62. Epub 2009 Apr 9.PMID: 19360016 [PubMed - indexed for MEDLINE]Related articles

23.

Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.

Sutton BS, Palmer ND, Langefeld CD, Xue B, Proctor A, Ziegler JT, Haffner SM, Norris JM, Bowden DW.

Diabetes. 2009 Jun;58(6):1457-62. Epub 2009 Mar 26.PMID: 19324939 [PubMed - indexed for MEDLINE]Related articlesFree article

24.

Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.

Wing MR, Ziegler J, Langefeld CD, Ng MC, Haffner SM, Norris JM, Goodarzi MO, Bowden DW.

Hum Genet. 2009 Jun;125(5-6):615-26. Epub 2009 Mar 26.PMID: 19322589 [PubMed - indexed for MEDLINE]Related articles

25.

The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.

Mak KH, Bhatt DL, Shao M, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Topol EJ.

Eur Heart J. 2009 Apr;30(7):857-65. Epub 2009 Feb 20.PMID: 19233855 [PubMed - indexed for MEDLINE]Related articles

26.

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.

Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M.

Diabetes. 2009 May;58(5):1212-21. Epub 2009 Feb 17.PMID: 19223598 [PubMed - indexed for MEDLINE]Related articlesFree article

27.

Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study.

MacKay MF, Haffner SM, Wagenknecht LE, D'Agostino RB Jr, Hanley AJ.

Diabetes Care. 2009 May;32(5):956-8. Epub 2009 Feb 5.PMID: 19196891 [PubMed - indexed for MEDLINE]Related articlesFree article

28.

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.

Nephrol Dial Transplant. 2009 May;24(5):1663-71. Epub 2009 Jan 14.PMID: 19145003 [PubMed - indexed for MEDLINE]Related articles

29.

Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.

Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA.

J Clin Hypertens (Greenwich). 2008 Dec;10(12):894-903.PMID: 19120715 [PubMed - indexed for MEDLINE]Related articles

30.

Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

Talbert ME, Langefeld CD, Ziegler J, Mychaleckyj JC, Haffner SM, Norris JM, Bowden DW.

Hum Genet. 2009 Mar;125(2):153-62. Epub 2008 Dec 13.PMID: 19083014 [PubMed - indexed for MEDLINE]Related articles

31.

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.

Califf RM, Boolell M, Haffner SM, Bethel MA, McMurray J, Duggal A, Holman RR; NAVIGATOR Study Group.

Am Heart J. 2008 Oct;156(4):623-32.PMID: 18946890 [PubMed - indexed for MEDLINE]Related articles

32.

Determining the most appropriate components for a composite clinical trial outcome.

Bethel MA, Holman R, Haffner SM, Califf RM, Huntsman-Labed A, Hua TA, McMurray J.

Am Heart J. 2008 Oct;156(4):633-40. Epub 2008 Jul 31.PMID: 18926145 [PubMed - indexed for MEDLINE]Related articles

33.

Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.

Williams K, Tchernof A, Hunt KJ, Wagenknecht LE, Haffner SM, Sniderman AD.

Diabetes. 2008 Dec;57(12):3289-96. Epub 2008 Sep 22.PMID: 18809621 [PubMed - indexed for MEDLINE]Related articlesFree article

34.

Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.

Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, Kawamori R; Endocrine Society.

J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89. Epub 2008 Jul 29.PMID: 18664543 [PubMed - indexed for MEDLINE]Related articlesFree article

35.

Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.

Foy CG, Hsu FC, Haffner SM, Norris JM, Rotter JI, Henkin LF, Bryer-Ash M, Chen YD, Wagenknecht LE.

Am J Hypertens. 2008 Aug;21(8):910-6. Epub 2008 Jun 19.PMID: 18566594 [PubMed - indexed for MEDLINE]Related articlesFree article

36.

Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K; Working Group 1.

Circulation. 2008 Jul 8;118(2):e20-8. Epub 2008 Jun 19. No abstract available. PMID: 18566314 [PubMed - indexed for MEDLINE]Related articlesFree article

37.

The prevention of type 2 diabetes.

Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group.

Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. Epub 2008 May 20. Review.PMID: 18493227 [PubMed - indexed for MEDLINE]Related articlesFree article

38.

Type 2 diabetes and the metabolic syndrome: national cholesterol education program guidelines and supporting evidence.

Haffner SM.

Crit Pathw Cardiol. 2004 Sep;3(3 Suppl):S12-4. No abstract available. PMID: 18340162 [PubMed - in process]Related articles

40.

Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.

Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM.

Clin J Am Soc Nephrol. 2008 May;3(3):783-9. Epub 2008 Mar 5.PMID: 18322051 [PubMed - indexed for MEDLINE]Related articlesFree article

41.

Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.

Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, Haffner SM, Bryer-Ash M, Bergman RN, Wagenknecht LE, Taylor KD, Rotter JI, Bowden DW.

Diabetes. 2008 Apr;57(4):1093-100. Epub 2008 Feb 5.PMID: 18252897 [PubMed - indexed for MEDLINE]Related articlesFree article

42.

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

43.

Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans.

Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, Hartiala J, Lehtinen AB, Haffner SM, Bergman RN, McEachin RC, Kjos SL, Lawrence JM, Buchanan TA, Watanabe RM.

Diabetes. 2008 Apr;57(4):1048-56. Epub 2007 Dec 27.PMID: 18162503 [PubMed - indexed for MEDLINE]Related articlesFree article

44.

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group.

Diabetes Care. 2008 Mar;31(3):420-6. Epub 2007 Dec 10.PMID: 18071002 [PubMed - indexed for MEDLINE]Related articlesFree article

45.

Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.

Rose DP, Haffner SM, Baillargeon J.

Endocr Rev. 2007 Dec;28(7):763-77. Epub 2007 Nov 2. Review.PMID: 17981890 [PubMed - indexed for MEDLINE]Related articlesFree article

46.

Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.

Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW.

J Clin Endocrinol Metab. 2008 Jan;93(1):304-9. Epub 2007 Oct 30.PMID: 17971425 [PubMed - indexed for MEDLINE]Related articlesFree article

47.

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM.

Circulation. 2007 Oct 23;116(17):1942-51.PMID: 17965405 [PubMed - indexed for MEDLINE]Related articlesFree article

48.

Unmet needs in controlling metabolic disease.

Haffner SM.

Rev Cardiovasc Med. 2007;8 Suppl 4:S17-24. Review.PMID: 17934390 [PubMed - indexed for MEDLINE]Related articles

49.

Abdominal adiposity and cardiometabolic risk: do we have all the answers?

Haffner SM.

Am J Med. 2007 Sep;120(9 Suppl 1):S10-6; discussion S16-7. Review.PMID: 17720354 [PubMed - indexed for MEDLINE]Related articles

50.

The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.

Hunt KJ, Williams K, Hazuda HP, Stern MP, Haffner SM.

Ann Epidemiol. 2007 Nov;17(11):870-7. Epub 2007 Jul 27.PMID: 17662617 [PubMed - indexed for MEDLINE]Related articlesFree article

Supplemental Content

Find related data

Search details

» See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

» See more...